
### [MONDO:0018660](http://purl.obolibrary.org/obo/MONDO_0018660)
**Label:** hemophilia

**Subclasses:** [MONDO:0015721](http://purl.obolibrary.org/obo/MONDO_0015721) (mild hemophilia a), [MONDO:0015787](http://purl.obolibrary.org/obo/MONDO_0015787) (symptomatic form of hemophilia a in female carriers), [MONDO:0010604](http://purl.obolibrary.org/obo/MONDO_0010604) (hemophilia b), [MONDO:0015720](http://purl.obolibrary.org/obo/MONDO_0015720) (Moderately severe hemophilia a), [MONDO:0015719](http://purl.obolibrary.org/obo/MONDO_0015719) (severe hemophilia a), [MONDO:0007596](http://purl.obolibrary.org/obo/MONDO_0007596) (factor VIII deficiency), [MONDO:0015716](http://purl.obolibrary.org/obo/MONDO_0015716) (Moderately severe hemophilia b), [MONDO:0015715](http://purl.obolibrary.org/obo/MONDO_0015715) (severe hemophilia b), [MONDO:0015717](http://purl.obolibrary.org/obo/MONDO_0015717) (mild hemophilia b), [MONDO:0010602](http://purl.obolibrary.org/obo/MONDO_0010602) (hemophilia a), [MONDO:0015788](http://purl.obolibrary.org/obo/MONDO_0015788) (symptomatic form of hemophilia b in female carriers), 

**Corr. equiv. classes:** [OMIM:306700](http://purl.obolibrary.org/obo/OMIM_306700), [Orphanet:169808](http://www.orpha.net/ORDO/Orphanet_169808), [OMIM:134500](http://purl.obolibrary.org/obo/OMIM_134500), [OMIM:306900](http://purl.obolibrary.org/obo/OMIM_306900), [Orphanet:169805](http://www.orpha.net/ORDO/Orphanet_169805), [Orphanet:169802](http://www.orpha.net/ORDO/Orphanet_169802), [Orphanet:169796](http://www.orpha.net/ORDO/Orphanet_169796), [Orphanet:177929](http://www.orpha.net/ORDO/Orphanet_177929), [Orphanet:177926](http://www.orpha.net/ORDO/Orphanet_177926), [Orphanet:98878](http://www.orpha.net/ORDO/Orphanet_98878), [Orphanet:98879](http://www.orpha.net/ORDO/Orphanet_98879), [Orphanet:169799](http://www.orpha.net/ORDO/Orphanet_169799), [Orphanet:169793](http://www.orpha.net/ORDO/Orphanet_169793), 

**Class expressions from DL-Learner:**

- [HP:0005261](http://purl.obolibrary.org/obo/HP_0005261) (Joint hemorrhage) and [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) 48.72%
- [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and [HP:0011029](http://purl.obolibrary.org/obo/HP_0011029) (Internal hemorrhage) and [HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology) 47.01%
- [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and [HP:0011028](http://purl.obolibrary.org/obo/HP_0011028) (Abnormality of blood circulation) and [HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology) 47.01%
- [HP:0001367](http://purl.obolibrary.org/obo/HP_0001367) (Abnormal joint morphology) and [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and [HP:0011029](http://purl.obolibrary.org/obo/HP_0011029) (Internal hemorrhage) 47.01%
- [HP:0001367](http://purl.obolibrary.org/obo/HP_0001367) (Abnormal joint morphology) and [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and [HP:0011028](http://purl.obolibrary.org/obo/HP_0011028) (Abnormality of blood circulation) 47.01%
- [HP:0001367](http://purl.obolibrary.org/obo/HP_0001367) (Abnormal joint morphology) and [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) 47.01%
- [HP:0001367](http://purl.obolibrary.org/obo/HP_0001367) (Abnormal joint morphology) and [HP:0001892](http://purl.obolibrary.org/obo/HP_0001892) (Abnormal bleeding) and [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) 47.01%
- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) and [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and [HP:0011029](http://purl.obolibrary.org/obo/HP_0011029) (Internal hemorrhage) 47.01%
- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) and [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and [HP:0011028](http://purl.obolibrary.org/obo/HP_0011028) (Abnormality of blood circulation) 47.01%
- [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and [HP:0011029](http://purl.obolibrary.org/obo/HP_0011029) (Internal hemorrhage) 45.54%
- [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and [HP:0011028](http://purl.obolibrary.org/obo/HP_0011028) (Abnormality of blood circulation) 45.54%
- [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) 43.12%
- [HP:0003256](http://purl.obolibrary.org/obo/HP_0003256) (Abnormality of the coagulation cascade) and [HP:0005261](http://purl.obolibrary.org/obo/HP_0005261) (Joint hemorrhage) 42.11%
- [HP:0001367](http://purl.obolibrary.org/obo/HP_0001367) (Abnormal joint morphology) and [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) 42.11%
- [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and [HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology) 39.64%


